The Effectiveness and Safety of Tenofovir Alafenamide in the Treatment of Chronic Hepatitis B Patients With Mildly Elevated Alanine Aminotransferase and Significant Liver Injury.
Clinical trial NCT04674423 · UNKNOWN
Trial details
- NCT number
- NCT04674423
- Sponsor
- National Cheng-Kung University Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-14
- Primary completion
- 2025-12-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.